Recursion Pharmaceuticals
RXRX
#4161
Rank
S$2.80 B
Marketcap
$6.97
Share price
1.84%
Change (1 day)
-45.02%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -S$0.63 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are S$58.48 Million. a decrease over its 2023 earnings that were of -S$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.63 Billion39.51%
2023 -S$0.45 Billion38.68%
2022 -S$0.33 Billion30.46%
2021 -S$0.25 Billion114.28%
2020 -S$0.12 Billion